XTANT MEDICAL HOLDINGS, INC. Operating Lease, Expense
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Operating Lease, Expense of $1.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-03-31
- XTANT MEDICAL HOLDINGS, INC. operating lease, expense for the quarter ending 2025-12-31 was $300.00K.
- XTANT MEDICAL HOLDINGS, INC. operating lease, expense for the quarter ending 2025-09-30 was $400.00K.
- XTANT MEDICAL HOLDINGS, INC. operating lease, expense for the quarter ending 2021-03-31 was $100.00K, a 0.00% change year-over-year.
- XTANT MEDICAL HOLDINGS, INC. operating lease, expense for the quarter ending 2020-03-31 was $100.00K.
- XTANT MEDICAL HOLDINGS, INC. operating lease, expense for fiscal 2025 was $1.20M, a 33.33% increase from fiscal 2024.
- XTANT MEDICAL HOLDINGS, INC. operating lease, expense for fiscal 2024 was $900.00K, a 28.57% increase from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. operating lease, expense for fiscal 2023 was $700.00K, a 16.67% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. operating lease, expense for fiscal 2022 was $600.00K, a 0.00% change from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $700.00K derived: sum of 2 quarters · filed 2026-03-31 | $1.20M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $900.00K 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $500.00K 10-Q · filed 2025-08-12 | ||||
| 2024-12-31 | $900.00K 10-K · filed 2026-03-31 | ||||
| 2023-12-31 | $700.00K 10-K · filed 2025-03-06 | ||||
| 2022-12-31 | $600.00K 10-K · filed 2024-04-01 | ||||
| 2021-12-31 | $600.00K 10-K · filed 2023-03-07 | ||||
| 2021-03-31 | $100.00K 10-Q · filed 2021-05-11 | ||||
| 2020-12-31 | $600.00K 10-K · filed 2022-03-08 | ||||
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-11 | $300.00K derived: sum of 2 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $600.00K 10-K · filed 2021-02-24 | $588.00K 10-K · filed 2020-03-05 | ||
| 2019-09-30 | $400.00K 10-Q · filed 2019-11-07 | ||||
| 2018-09-30 | $900.00K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |